Your browser doesn't support javascript.
loading
Calibrating a network meta-analysis of diabetes trials of sodium glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population: a systematic review protocol.
Butterly, Elaine; Wei, Lili; Adler, Amanda I; Almazam, Saleh A M; Alsallumi, Khalid; Blackbourn, Luke A K; Dias, Sofia; Hanlon, Peter; Hughes, Katherine; Lewsey, Jim; Lindsay, Robert; McGurnaghan, Stuart; Petrie, John; Phillippo, David; Sattar, Naveed; Tomlinson, Laurie A; Welton, Nicky; Wild, Sarah; McAllister, David.
Affiliation
  • Butterly E; School of Health and Wellbeing, University of Glasgow, Glasgow, UK.
  • Wei L; School of Health and Wellbeing, University of Glasgow, Glasgow, UK.
  • Adler AI; Diabetes Trials Unit, University of Oxford, Oxford, UK.
  • Almazam SAM; School of Health and Wellbeing, University of Glasgow, Glasgow, UK.
  • Alsallumi K; School of Health and Wellbeing, University of Glasgow, Glasgow, UK.
  • Blackbourn LAK; Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
  • Dias S; Centre for Reviews and Dissemination, University of York, York, Select State, UK.
  • Hanlon P; School of Health and Wellbeing, University of Glasgow, Glasgow, UK.
  • Hughes K; Department of Diabetes, Glasgow Royal Infirmary, NHS Greater Glasgow and Clyde, Glasgow, Glasgow, UK.
  • Lewsey J; School of Health and Wellbeing, University of Glasgow, Glasgow, UK.
  • Lindsay R; University of Glasgow BHF Glasgow Cardiovascular Research Centre, Glasgow, Glasgow, UK.
  • McGurnaghan S; Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
  • Petrie J; University of Glasgow BHF Glasgow Cardiovascular Research Centre, Glasgow, Glasgow, UK.
  • Phillippo D; Population Health Sciences, University of Bristol, Bristol, UK.
  • Sattar N; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
  • Tomlinson LA; Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
  • Welton N; Population Health Sciences, University of Bristol, Bristol, UK.
  • Wild S; Public Health Sciences, University of Edinburgh, Edinburgh, UK.
  • McAllister D; School of Health and Wellbeing, University of Glasgow, Glasgow, UK david.mcallister@glasgow.ac.uk.
BMJ Open ; 12(10): e066491, 2022 10 27.
Article in En | MEDLINE | ID: mdl-36302574
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Dipeptidyl-Peptidase IV Inhibitors / Sodium-Glucose Transporter 2 Inhibitors Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Aspects: Ethics Limits: Humans Language: En Journal: BMJ Open Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Dipeptidyl-Peptidase IV Inhibitors / Sodium-Glucose Transporter 2 Inhibitors Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Aspects: Ethics Limits: Humans Language: En Journal: BMJ Open Year: 2022 Document type: Article Affiliation country: Country of publication: